Icosavax Inc (ICVX): A Case For Going Higher

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $15.21 and fluctuated between $15.32 as its day high and $15.18 as its day low. The current market capitalization of Icosavax Inc is $761.87M. A total of 0.89 million shares were traded on the day, compared to an average of 918.48K shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, ICVX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 4 BUYs and 17 SELLs from insiders. Insiders purchased 50,476 shares during that period but sold 95,519.

In the most recent transaction, Simpson Adam K. sold 15,000 shares of ICVX for 15.67 per share on Jan 02. After the transaction, the Chief Executive Officer now owns 260,641 company shares. In a previous transaction on Dec 21, Simpson Adam K. sold 90,000 shares at 15.44 per share. ICVX shares that Chief Executive Officer owns now total 260,641.

Among the insiders who sold shares, Simpson Adam K. disposed of 62,205 shares on Dec 20 at a per-share price of $15.46. This resulted in the Chief Executive Officer holding 184,724 shares of ICVX after the transaction. In another insider transaction, Russo Thomas Joseph sold 15,183 shares at $15.46 per share on Dec 20. Company shares held by the Chief Financial Officer now total 38,037.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ICVX has a high of $16.10 and a low of $4.75.

As of this writing, ICVX has an earnings estimate of -$0.52 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.46 per share and a lower estimate of -$0.59. The company reported an EPS of -$0.59 in the last quarter, which was 1.70% higher than expectations of -$0.6.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ICVX’s latest balance sheet shows that the firm has $279.08M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $9.24M in liabilities at the time. Its Book Value Per Share was $4.64, while its Total Shareholder’s Equity was $278.22M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ICVX is Buy with a score of 4.00.

Most Popular

Related Posts